Maser settled for halfof the performance shares which the company said were worth nothing but he obviously doesn't.
There has to be revenue that hasn't been getting reported so I am guessing that that is his case. Not reporting co-bottling revenue shouldnt negate the fact that there is some value there.
We got a little closer to our objective judging from a nr where Samuel Adams has launched a thc infused iced tea.
Seems to be more reporting of cannabinoid infused beverages being sold in bars too which is an essential for this type of sku to get full traction.
Revenue doesn't mean profit but it is step one towards getting to profit.
Tinley has made a few faux pas's along the way including not giving shareholders some numbers to digest.
Production numbers if we can't get revenue numbers.
We should be back up and running soon which should generate co-bottling revenue or a kick back on it from Blaze.
What Tinley will have left is our cannabinoid infused skus, both tonics and rtds and Becketts faux liqueres and rtd offerings which some are excited about.
We need to be able to have a consistant supply and a real salesforce in the States where legal. I hope our recipes are worth their awards.
What I really hope for is a suitor with deep pockets.
glta and dyodd